All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ASCA101Phase 21 trial

    MetaFines · Cachexia; Cancer

  • ASKG915Phase 21 trial

    AskGene Pharma, Inc. · Advanced Solid Tumors

  • ASN-3186Phase 21 trial

    Jiangsu Yahong Meditech Co., Ltd aka Asieris · Advanced Solid Tumors

  • ASP2998Phase 21 trial

    Astellas · Locally Advanced or Metastatic Malignant Solid Tumors

  • ASP388BPhase 21 trial

    Astellas · Locally Advanced or Metastatic Solid Tumors

  • ASP5541PRL-02Phase 21 trial

    Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer

  • AST-201Phase 21 trial

    Aston Sci. Inc. · Advanced Ovarian Cancer

  • AST-301pNGVL3-hICDPhase 21 trial

    Aston Sci. Inc. · Gastric Cancer

  • ASTX660Phase 21 trial

    Taiho Oncology, Inc. · Solid Tumors, Lymphoma

  • atamparibPhase 21 trial

    Nerviano Medical Sciences (Shanghai) Ltd. · NSCLC Adenocarcinoma, Solid Tumor

  • atilizumabPhase 21 trial

    Abbisko Therapeutics Co, Ltd · Hepatocellular Carcinoma

  • ATRN-119Phase 21 trial

    Aprea Therapeutics · Advanced Solid Tumor

  • ATTR-01Phase 21 trial

    Accession Therapeutics Limited · Solid Tumor, Adult

  • ATX-295Phase 21 trial

    Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer

  • ATX-898Phase 21 trial

    Antares Therapeutics, Inc · Advanced Solid Tumors

  • AU-007Phase 21 trial

    Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma

  • AVZO-023Phase 21 trial

    Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer

  • AVZO-103Phase 21 trial

    Avenzo Therapeutics, Inc. · Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors

  • AVZO-1418Phase 21 trial

    Avenzo Therapeutics, Inc. · Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors

  • AZD0516Phase 21 trial

    AstraZeneca · Metastatic Prostate Cancer

  • AZD0754Phase 21 trial

    AstraZeneca · Metastatic Prostate Cancer

  • AZD2811Phase 21 trial

    AstraZeneca · Small-Cell Lung Cancer

  • AZD4360Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer

  • AZD4635Phase 21 trial

    AstraZeneca · Carcinoma, Non-Small-Cell Lung

  • AZD4956Phase 21 trial

    AstraZeneca · Solid Tumours

  • AZD5851Cell TherapyPhase 21 trial

    AstraZeneca · Hepatocellular Carcinoma

  • AZD5863Phase 21 trial

    AstraZeneca · Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma

  • AZD6621Phase 21 trial

    AstraZeneca · Prostate Cancer

  • AZD6750Phase 21 trial

    AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)

  • AZD7789Phase 21 trial

    AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer

  • AZD8205Phase 21 trial

    AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer

  • AZD8359Phase 21 trial

    AstraZeneca · Metastatic Prostate Cancer

  • AZD8421Phase 21 trial

    AstraZeneca · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)

  • AZD9750Phase 21 trial

    AstraZeneca · Prostate Cancer

  • AZD9793Phase 21 trial

    AstraZeneca · Hepatocellular Carcinoma

  • Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor

  • B013Phase 21 trial

    Shanghai Jiaolian Drug Research and Development Co., Ltd · Platinum-resistant Recurrent Ovarian Cancer

  • BalstililmabPhase 21 trial

    Nelum Corp · Untreated, Advanced Pancreatic Cancer

  • BAT1006Phase 21 trial

    Bio-Thera Solutions · Advanced Solid Tumors

  • BAT8008Phase 21 trial

    Bio-Thera Solutions · Advanced Solid Tumors

  • BAT8010Phase 21 trial

    Bio-Thera Solutions · Advanced Solid Tumors

  • BAY 3713372Phase 21 trial

    Bayer · MTAP-deleted Solid Tumors

  • BB-1701Phase 21 trial

    Eisai · Breast Cancer

  • BB102Phase 21 trial

    Broadenbio Ltd., Co. · Hepatocellular Carcinoma (HCC)

  • BBT-207Phase 21 trial

    Bridge Biotherapeutics, Inc. · EGFR Mutant Advanced Non-Small Cell Lung Cancer

  • BC3195Phase 21 trial

    Biocity Biopharmaceutics Co., Ltd. · Locally Advanced or Metastatic Solid Tumors

  • BCB-276Phase 21 trial

    BrainChild Bio, Inc · Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor

  • BCD-236Phase 21 trial

    Biocad · Triple Negative Breast Cancer

  • BDC-4182Phase 21 trial

    Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma

  • BerubicinPhase 21 trial

    CNS Pharmaceuticals, Inc. · Glioblastoma Multiforme, Adult

NewerPage 15 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.